O

Olatec Therapeutics

0 followers

Olatec is a privately held biopharmaceutical company developing a platform of safe, oral NLRP3 antagonist therapeutics, to treat and prevent a broad spectrum of acute and chronic inflammatory diseases that are known to be mediated by Interleukin-1 (IL-1), including: arthritis, heart failure, asthma,... Read more

Industries

Employees

1-10

Links

This is an unverified company page

Org chart

Damaris B. Skouras' profile picture
Damaris B. Skouras
Founder, Chairman & CEO
Collapse
Charles A. Dinarello
Chairman, SAB & co-Chief Scientific Officer
Joseph St. Laurent's profile picture
Joseph St. Laurent
Co-Chief Scientific Officer
Cynthia (Dana) Barrow's profile picture
Cynthia (Dana) Barrow
VP Compliance And Risk
Jeanette Rooney, CPA, CGMA's profile picture
Jeanette Rooney, CPA, CGMA
Vice President Finance & Treasurer
Piscitelli Philip's profile picture
Piscitelli Philip
Vice President, Clinical Development Operations
Sophia Hughes
Investor Relations, Public Relations & Communications

Board & advisors

Antonio Abbate
Scientific Advisor
William J. Cunningham
Scientific Advisor
Robert H. Dworkin
Scientific Advisor
Robert M. Fielding
Scientific Advisor
Shayne C. Gad
Scientific Advisor
Leo A. B. Joosten
Scientific Advisor
Viola T. Kung
Scientific Advisor
Peter Libby
Scientific Advisor
Howard I. Maibach
Scientific Advisor
Alberto Mantovani
Scientific Advisor
Steven B. Newhard
Scientific Advisor
Marc J. Philippon
Scientific Advisor
Amy K. Poshusta
Scientific Advisor
Lucio C. Rovati
Scientific Advisor
F. Kip Vought
Scientific Advisor
Timotheus Jansen
Clinical Advisor
Matthijs Janssen
Clinical Advisor
Daniel Yadegar
Clinical Advisor
Andrea Leonard-Segal
Scientific Advisor

Teams


Offices